Moreover, we found that the application of survivin inhibitor YM155 impaired the inhibitory abilities of DSE in ESCC cells, which suggested that survivin played a critical role in DSE against ESCC. This evidence concerns the gene BIRC5 and esophageal squamous cell carcinoma.